LCTX · Lineage Cell Therapeutics, Inc. · Exempt Offerings
$0.93
0.00 (-0.31%)
At close · Oct 5
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$260.49M
Shares
252.91M
Volume · Oct 5
1.39M
Avg daily vol (3M)
1.14M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.